The effect of contrast agents on the anticoagulant properties of oral factor Xa inhibitors.

Cavlan, Burcu; Ari, Selma; Ari, Hasan; Çamci, Sencer; Melek, Mehmet; Bozat, Tahsin

Cavlan, Burcu; Ari, Selma; Ari, Hasan; Çamci, Sencer; Melek, Mehmet; Bozat, Tahsin.

Afiliação

Cavlan B; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.
Ari S; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.
Ari H; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.
Çamci S; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.
Melek M; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.
Bozat T; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.

Acta Radiol ; 64(2): 588-595, 2023 Feb.

Article em En | MEDLINE | ID: mdl-35296141

Assuntos

Anticoagulantes; Fibrilação Atrial; Humanos; Anticoagulantes/farmacologia; Anticoagulantes/uso terapêutico; Inibidores do Fator Xa/farmacologia; Inibidores do Fator Xa/uso terapêutico; Rivaroxabana/farmacologia; Rivaroxabana/uso terapêutico; Meios de Contraste; Iohexol/farmacologia; Administração Oral

Palavras-chave

Oral anticoagulant; anti-factor Xa; atrial fibrillation; contrast agent; renal function

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Anticoagulantes Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google